About us
Our experts
Services
Our work
Client Cases
Publications
Insights
Careers
Contact
About us
Our experts
Services
Our work
Client Cases
Publications
Insights
Careers
Contact
Home
Publications
All areas of expertise
Climate, Energy, & Natural Resources
Competition
Dispute Support
Healthcare & Life Sciences
IP Valuation & Transfer Pricing
Postal & Delivery
State Aid
Tender & Auction Support
TMT & Digital
Filter publications:
Healthcare & Life Sciences
GSK
Rotavirus vaccine – Technical and economic arguments regarding implementation of rotavirus vaccination in the Danish immunisation programme
Healthcare & Life Sciences
US Hereditary Angioedema Association (HAEA)
Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency
Healthcare & Life Sciences
PhRMA
Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy
Healthcare & Life Sciences
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Cost and value of regulatory data protection
Healthcare & Life Sciences
EURORDIS, Alexion AstraZeneca Rare Disease, Takeda, Orphanet
Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products
Healthcare & Life Sciences
Novartis Healthcare A/S
Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark
Healthcare & Life Sciences
OD Expert Group
European Union Health Technology Assessment Fit for Rare Diseases
Healthcare & Life Sciences
Novo Nordisk A/S
European trade in pharmaceutical goods
Healthcare & Life Sciences
Alliance for Safe Online Pharmacy in the EU (ASOP EU)
Unlocking the benefits of online access to prescription medicines across the EU
Healthcare & Life Sciences
Novo Nordisk
The economic impact of the pharmaceutical industry in Europe
Healthcare & Life Sciences
PhRMA
Regulatory data protection – How adopting regulatory data protection can increase medicine availability, innovation, and investment
Healthcare & Life Sciences
Economists Without Borders / Impactly
New tool assesses the impact of initiatives against loneliness
Healthcare & Life Sciences
Takeda
Development of novel therapies
Healthcare & Life Sciences
Takeda
Innovating for people living with a rare disease
Healthcare & Life Sciences
Gilead Sciences, Inc.
The impact of remdesivir in the European Union
Healthcare & Life Sciences
Interfarma and PhRMA
Regulatory data protection for pharmaceuticals
1
2
3
Show more